Thrombogenicity of TNFα in rheumatoid arthritis defined through biological probes: TNFα blockers

Autoimmunity Reviews

Volumn 3, Issue 4, 2004, Pages 261-266

  Ferraccioli, Gianfranco ^a   Gremese, Elisa ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Cardiovascular risk; Rheumatoid arthritis; Thrombophilia; TNF ; TNF blockers; Vascular damage

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CARDIOLIPIN ANTIBODY; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CARDIOVASCULAR RISK; DRUG MECHANISM; HUMAN; IMMUNOREACTIVITY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; MORBIDITY; NONHUMAN; ORGAN INJURY; PHYSICIAN; PROTECTION; REVIEW; RHEUMATOID ARTHRITIS; SOLUBILITY; STATISTICAL SIGNIFICANCE; SYSTEMIC DISEASE; THROMBOGENICITY; TISSUE INJURY; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ANIMALS; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; HUMANS; IMMUNOGLOBULIN G; MYOCARDIAL INFARCTION; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; RISK FACTORS; THROMBOPHILIA; THROMBOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042816196     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2003.09.004     Document Type: Review

References (40)

1. Solomon D.H., Karlson E.W., Rimm E.B., Cannuscio C.C., Mandl L.A., Manosn J.E., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 107:2003;1303-1307
2. Wolfe F., Mitchell D.M., Sibley J.T., Fries J.F., Bloch D.A., Williams C.A., et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 37:1994;481-494
3. Platt N., Gordon S. Is the class A macrophage scavenger receptor (SR-A) multifunctional? the mouse's tale. J Clin Invest. 108:2001;649-654
4. Niedhala M.J., Stein-Picarella M. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Blood. 79:1992;678-687
5. Devaraj S., Xu D.Y., Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Implications for the metabolic syndrome and atherothrombosis. Circulation. 107:2003;398-404
6. Allison-Green E., Wong S.F., Eshima K., Mora C., Flavell R.A. Neonatal tumor necrosis factor promotes diabetes in non obese diabetic mice by CD154-independent antigen presentation to CD8+ T cells. J Exp Med. 191:2000;225-231
7. Jacob C.O., McDevitt H.O. Tumor necrosis factor a in murine autoimmune lupus nephritis. Nature. 331:1988;356-358
8. Saren P., Welgus H.G., Kovanen P.T. TNF alpha and IL1 beta selectively induce the expression of 92-kD gelatinase by human macrophages. J Immunol. 157:1996;4159-4165
9. Shimaoka T., Kume N., Hayashida K., Sawamura T., Kita T., Yonehara S. LOX-1 supports adhesion of gram-positive and gram-negative bacteria. J Immunol. 166:2001;5108-5114
10. Bevilacqua M.P., Pober J.S., Mendrick D.L., Cotran R.S., Gimbrone. Identification of an inducible endothelial-leukocyte adhesion molecule. PNAS. 84:1987;9238-9242
11. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., Springer T.A. Induction by IL1 and interferon gamma: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol. 137:1986;245-250
12. Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 21:2001;1876-1890
13. Nagase M., Abe J., Takahashi K., Ando J., Hirose S., Fujita T. Genomic organization and regulation of expression of the Lectin-like oxidized low density lipoprotein receptor (LOX-1) gene. J Biol Chem. 273:1998;33 702-33 707
14. Ludewig B., Freigang S., Jaggi M., Kurrer M.O., Pei Y.C., Vlk L., et al. Linking immune mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. PNAS. 97:2000;12 752-12 757
15. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Ann Rev Immunol. 14:1996;397-440
16. Kollias G., Kontoyannis D. Role of TNF/TNF R in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev. 13:2002;315-320
17. Lahn M., Kalataradi H., Mittelstadt P., Pflum E., Vollmer M., Cady C., et al. Early preferential stimulation of γδ T cells by TNFα J Immunol. 160:1998;5221-5230
18. Kleindienst R., Xu Q., Willeit J., Waldenberger F.R., Weimann S., Wick. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta and gamma/delta receptor in human atherosclerotic lesions. Am J Pathol. 142:1993;1927-1937
19. Libby P. Inflammation in atherosclerosis. Nature. 420:2002;868-874
20. Wong M.L., Xie B., Beatini N., Phu P., Marathe S., Johns A., et al. Acute systemic inflammation up-regulates sphingomyelinase in vivo:a possible link between inflammatory cytokines and atherogenesis. PNAS. 97:2000;8681-8686
21. Via C.S., Shustov A., Rus V., Lang T., Nguyen P., Finkelman F.D. In vivo neutralization of TNFa promotes humoral autoimmunity by preventing the induction of CTL. J Immunol. 167:2001;6821-6826
22. Fuji T., Okada M., Mimori T., Craft J. The transmembrane form of TNF a drives autoantibody production in the absence of CD154: studies using MRL/Mp-Faslpr mice. Clin Exp Immunol. 130:2002;224-230
23. Pepys M.B., Booth S.E., Tennent G.A., Butler P.J.G., Williams D.G. Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli. Clin Exp Immunol. 97:1994;152-157
24. Bickerstaff M.C.M., Botto M., Hutchinson W.L., Herbert J., Tennent G.A., Bybee A., et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med. 5:1999;694-697
25. Paul E., Carroll M. SAP-less chromatin triggers systemic lupus erythematosus. Nat Med. 5:1999;607-608
26. Shakoor N., Michalska M., Harris C.A., Block J.A. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet. 359:2002;579-580
27. Cairns A.P., Duncan M.K.J., Hinder A.E., Taggart A.J. New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis. Ann Rheum Dis. 61:2002;1031-1032. letter
28. Ali Y., Shah S. Infliximab induced systemic lupus erythematosus. Ann Int Med. 137:2002;625-626. letter
29. Ferraccioli G.F., Mecchia F., Di Poi E., Fabris M. Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible associations with infections. Ann Rheum Dis. 61:2002;358-361
30. Galli M., Luciani D., Beryolini G., Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anti-cardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 101:2003;1827-1832
31. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 20:2002;709-760
32. Ferraccioli G.F., Assaloni R., Di Poi E., Gremese E., De Marchi G., Fabris M. Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial. Rheumatology. 41:2002;1109-1112
33. Dewberry R., Holden H., Crossman D., Francis S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol. 20:2000;2394-2400
34. Kiriji H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, et al. Lack of interleukin 1 b decreases the severity of atherosclerosis in Apo-E deficient mice. Atheroscler Thromb Vasc Biol 2003;23:656-660
35. Long C.S. The role of IL1β in the failing heart. Heart Failure Rev. 6:2001;81-94
36. Devlin C.M., Kuriakose G., Hirsch E., Tabas I. Genetic alterations of IL1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size. PNAS. 99:2002;6280-6285
37. Bryant D., Becker L., Richardson J., Shelton J., Franco F., Peshock R., et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor α Circulation. 97:1998;1375-1381
38. Singh A.K., Mao C., Lebedeva T.V. In vitro role of IL1 in heightened IgG, anti-DNA and nephritogenic idiotype production by B cells derived from murine MRL/lpr lupus model. Clin Immunol Immunopathol. 72:1994;410-415
39. Pasceri V., Yeh E.T.H. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation. 100:1999;2124-2126
40. Blank M., Krause I., Fridkin M., Keller N., Kopolovic J., Goldberg I., et al. Bacterial induction of autoantibodies to β2glycoproteinI accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest. 109:2002;797-804